SCHEMBL5373554

SCHEMBL5373554

CN(C)CCN(CC(=O)Nc1ccc(Oc2ccccc2)cc1)Cc1ccc(Br)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 12/20 0.57
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.49
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
RNF4 P78317 1/20 0.44
NPY5R Q15761 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5662666 0.87 LTA4H (0.56) LTA4HALDH1A1GAAKDM4EL3MBTL1
SCHEMBL5662457 0.84 LTA4H (0.68) LTA4HALDH1A1GAAKDM4EL3MBTL1
SCHEMBL5313799 0.78 MAPT (0.62) LTA4HALDH1A1KDM4E
SCHEMBL5311089 0.78 LTA4H (0.62) LTA4HALDH1A1GAAKDM4EMEN1
SCHEMBL5656997 0.78 LTA4H (0.62) LTA4HALDH1A1GAAKDM4E
SCHEMBL5661889 0.78 LTA4H (0.85) LTA4HALDH1A1GAAKDM4EL3MBTL1
SCHEMBL5658771 0.77 LTA4H (0.56) LTA4HALDH1A1GAAL3MBTL1NPY5R
SCHEMBL5660589 0.77 LTA4H (0.61) LTA4HALDH1A1GAAKDM4EHDAC1
SCHEMBL5659243 0.75 LTA4H (0.53) LTA4HALDH1A1GAANPY5R
SCHEMBL5660215 0.73 LTA4H (0.82) LTA4HALDH1A1GAAKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007079003-A2 AMIDE INHIBITORS OF LEUKOTRIENE A4 HYDROLASE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-07-12 WO disclosed
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase SCHERING AKTIENGESSELLSCHAFT (DE) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155727-A1 Amide inhibitors of leukotriene A4 hydrolase LTA4H, LTB4R, LTC4S LTA4H 1/4885ALDH1A1 1337/4885GAA 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.